XL 40 (Cabometyx 40 mg)
Generic Name: cabozantinib
Pill with imprint XL 40 is Yellow, Three-sided and has been identified as Cabometyx 40 mg. It is supplied by Exelixis, Inc.
Cabometyx is used in the treatment of renal cell carcinoma; thyroid cancer; hepatocellular carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cabometyx 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for XL 40
Cabometyx
- Generic Name
- cabozantinib
- Imprint
- XL 40
- Strength
- 40 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Exelixis, Inc.
- National Drug Code (NDC)
- 42388-0025
- Inactive Ingredients
-
microcrystalline cellulose,
lactose anhydrous,
hydroxypropyl cellulose,
croscarmellose sodium,
silicon dioxide,
magnesium stearate,
hypromelloses,
titanium dioxide,
triacetin,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "XL 40"
More about Cabometyx (cabozantinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (7)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
- Other brands
- Cometriq
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.